We’re creating what’s next, together.

Genentech’s partnership with the hemophilia community began over 30 years ago when we developed our first medicine to help people with hemophilia A.* This partnership continues today through a lasting commitment to the hemophilia community that goes far beyond providing medicines.

*Genentech outlicensed worldwide production and marketing of factor VIII.

We’re committed to advancing all aspects of life with hemophilia, starting with patient care. 

We strive to provide Treatment for All who need it, including underserved communities around the globe

We strive to provide Treatment for All who need it, including underserved communities around the globe.

Genentech and our parent company Roche are partnering with the World Federation of Hemophilia (WFH) and Save One Life to provide humanitarian aid and economic opportunities to underserved communities around the globe.

CHALLENGE ACCEPTED web series hosted by Justin Willman

We Connect the Community through active engagements that help bring these individuals together to learn and grow.

Watch the web series that puts the real everyday challenges of living with hemophilia to the test.

We Suport the Person through education, resources, and tools designed to help individuals thrive throughout their treatment journey

We Support the Person through education, resources, and tools designed to help individuals thrive throughout their treatment journey.

Discover workshops designed to help you think well, do well, and be well.

With your help, we will continue to deliver on the needs of the community.